Cloudleaf - Technical Innovation of the Year

Company: Cloudleaf, Santa Clara, CA
Entry Submitted By: 10Fold
Company Description: Cloudleaf powers next generation digital supply chains and enables 24/7 cold chain monitoring with insights from objective and clear ground truth and real-time decision-making through its SaaS platform, which leverages hyper-scale cloud, digital twin, AI/ML and IoT technologies to deliver continuous visibility and intelligence.
Nomination Category: Company / Organization Categories
Nomination Sub Category: Technical Innovation of the Year - At Organizations With Up to 100 Employees

Nomination Title: Cloudleaf

Cloudleaf was founded on a compelling vision: take a radical new approach to unlock the massive value within supply chains, and transform them into more powerful, data-driven strategic assets. Cloudleaf was founded in 2014 by a team of Silicon Valley veterans with backgrounds in cloud technologies, embedded software and radio networks. https://www.cloudleaf.com/about/leadership/

Cloudleaf powers next generation digital supply chains with insights from ground truth and real-time decision-making. Its SaaS platform leverages hyper-scale cloud, digital twin, Artificial Intelligence (AI), Machine Learning (ML) and IoT technologies to deliver continuous visibility and intelligence. Cloudleaf enables business leaders to make the right decisions in real time to increase revenues, avoid disruptions, deliver better business outcomes, improve customer satisfaction and increase sustainability.

After securing a $26 million series B funding round in August 2019, Cloudleaf has continued to expand its ecosystem, assembling a world-class and active board of advisors and recruiting key industry leaders -- including Former Executive Chairman and CEO of Cisco Systems John Chambers as a strategic advisor, investor and mentor.
https://www.cloudleaf.com/news/cloudleaf-announces-26-million-series-b-funding/
https://www.cloudleaf.com/about/advisors/
https://www.cloudleaf.com/news/john-chambers-former-executive-chairman-and-ceo-of-cisco-systems-joins-cloudleaf-as-strategic-advisor-investor-and-mentor/

In June 2020, Cloudleaf also partnered with CSafe, a provider of end-to-end thermal shipping solutions for the global pharmaceutical and life sciences industries, to pair Cloudleaf’s digital visibility platform with CSafe’s temperature-controlled container solutions to address the pharmaceutical supply chain industry’s critical cold chain challenges. By using IoT, AI/ML and advanced analytics, Cloudleaf’s cloud software enables organizations to digitize their supply chain, while processing billions of events per second to deliver diagnostic and predictive insights in real-time for location, condition, utilization and anomaly detection. As a result, customers like CSafe are able to closely monitor all activity going on within their supply chain and intervene if needed to preserve products.https://csafeglobal.com/

With 50% of vaccines lost annually due to process failures in cold chains, this partnership comes at a critical time as the global pharma supply chain races to prepare for a large-scale distribution of a COVID-19 vaccine. It has become more imperative than ever for the pharmaceutical industry to have the ability to track shipments in real-time and access that realtime data for compliance requirements to successfully deliver medicines and vaccines to the patients who need them. https://apps.who.int/iris/bitstream/handle/10665/68463/WHO_VB_03.18.Rev.1_eng.pdf?sequence=1&;isAllowed=y

Track-and-trace technology and visibility software are transforming the cold chain and pharmaceutical industry. The highly complex pharma cold chain requires properly functioning storage/packaging, transit, and shipping solutions. Given the high number of transfers from manufacturer to end customer, any kind of logistics or cold transport problems are devastating.

Historically, cold chain issues cost biopharma approximately $35 billion dollars each year as a result of failures in temperature-controlled logistics. Pharmaceutical manufacturers rely on the cold chain industry to deliver life-saving products in the right condition, at the right time, place and cost. Cloudleaf’s Platform enables organizations to easily manage and track shipments to ensure that customers’ products arrive at the correct destinations within the designated time frame to remain viable to effectively treat the patients who need these treatments most. https://www.biocair.com/knowledge/white-papers-technical-articles/cold-chain-challenge#:~:text=According%20to%20The%20IQVIA%20Institute,failures%20across%20their%20supply%20chains

Supply chain organizations will play a critical role in bringing an end to the COVID-19 pandemic, but must first prepare to accommodate the complex cold chain requirements of the COVID-19 vaccine. This challenge goes beyond COVID-19, as many patients with other life-threatening illnesses (e.g. cancer) rely on properly functioning end-to-end cold chains to safely deliver life-saving medications on time, in the correct quantities and quality condition. The global supply chain disruption demonstrated by COVID-19 has threatened to cause a cancer drug shortage, particularly chemotherapies, potentially leading to an increase in counterfeit drugs and further jeopardizing patient safety. Cloudleaf is helping make leaps and bounds in a space that can ultimately mean the difference between life and death for patients. https://www.pharmaceutical-technology.com/comment/cancer-drug-shortages-covid-19/

To learn more about Cloudleaf’s and CSafe’s partnership, take a look at the press release. https://www.businesswire.com/news/home/20200723005216/en/CSafe-Global-Selects-Cloudleaf-as-Strategic-Partner-to-Deliver-a-New-Digital-Visibility-Platform

Additionally, learn more about the Cloudleaf Digital Visibility platform’s capabilities here. https://www.cloudleaf.com/platform/

Hear Mahesh Veerina, Cloudleaf CEO discuss how the pharma supply chain is preparing the global pharma supply chain for a worldwide COVID-19 vaccine distribution in his two part interview with Manufacturing Chemist:
Part One
https://www.manufacturingchemist.com/technical/article_page/Scalingup_the_pharmaceutical_supply_chain_with_digitisation_part_I/170530
Part Two
https://www.manufacturingchemist.com/technical/article_page/Scalingup_the_pharmaceutical_supply_chain_with_digitisation_part_II/170770